These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26160630)

  • 1. Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy.
    Woitek F; Zentilin L; Hoffman NE; Powers JC; Ottiger I; Parikh S; Kulczycki AM; Hurst M; Ring N; Wang T; Shaikh F; Gross P; Singh H; Kolpakov MA; Linke A; Houser SR; Rizzo V; Sabri A; Madesh M; Giacca M; Recchia FA
    J Am Coll Cardiol; 2015 Jul; 66(2):139-53. PubMed ID: 26160630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy.
    Pepe M; Mamdani M; Zentilin L; Csiszar A; Qanud K; Zacchigna S; Ungvari Z; Puligadda U; Moimas S; Xu X; Edwards JG; Hintze TH; Giacca M; Recchia FA
    Circ Res; 2010 Jun; 106(12):1893-903. PubMed ID: 20431055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary Gene Delivery of the Cytoprotective Factor Vascular Endothelial Growth Factor-B
    Paradies P; Carlucci L; Woitek F; Staffieri F; Lacitignola L; Ceci L; Romano D; Sasanelli M; Zentilin L; Giacca M; Salvadori S; Crovace A; Recchia FA
    Vet Sci; 2019 Mar; 6(1):. PubMed ID: 30845635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B
    Lottonen-Raikaslehto L; Rissanen R; Gurzeler E; Merentie M; Huusko J; Schneider JE; Liimatainen T; Ylä-Herttuala S
    Physiol Rep; 2017 Mar; 5(6):. PubMed ID: 28351964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration.
    Toyoda Y; Okada M; Kashem MA
    J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1367-73. PubMed ID: 9628680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats.
    Serpi R; Tolonen AM; Huusko J; Rysä J; Tenhunen O; Ylä-Herttuala S; Ruskoaho H
    Cardiovasc Res; 2011 Jan; 89(1):204-13. PubMed ID: 20733007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting Old Players in the Revitalized Field of Cardiovascular Gene Therapy.
    Ishikawa K; Hajjar RJ
    J Am Coll Cardiol; 2015 Jul; 66(2):166-8. PubMed ID: 26160632
    [No Abstract]   [Full Text] [Related]  

  • 8. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
    Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.
    Kanda M; Nomoto S; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    J Surg Oncol; 2008 Sep; 98(3):190-6. PubMed ID: 18537151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: A novel gene therapy for cardiomyopathy.
    Ahmet I; Sawa Y; Iwata K; Matsuda H
    J Thorac Cardiovasc Surg; 2002 Nov; 124(5):957-63. PubMed ID: 12407379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
    Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
    Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine Model of Pacing-Induced Heart Failure.
    Powers JC; Recchia F
    Methods Mol Biol; 2018; 1816():309-325. PubMed ID: 29987830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
    Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
    J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
    Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
    Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
    Shirasaka T; Miyagawa S; Fukushima S; Saito A; Shiozaki M; Kawaguchi N; Matsuura N; Nakatani S; Sakai Y; Daimon T; Okita Y; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):413-21. PubMed ID: 23541854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy in large animal models of human cardiovascular genetic disease.
    Sleeper MM; Bish LT; Sweeney HL
    ILAR J; 2009; 50(2):199-205. PubMed ID: 19293462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis.
    Lazarous DF; Shou M; Stiber JA; Hodge E; Thirumurti V; Gonçalves L; Unger EF
    Cardiovasc Res; 1999 Nov; 44(2):294-302. PubMed ID: 10690306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.
    Kawada T; Nakazawa M; Nakauchi S; Yamazaki K; Shimamoto R; Urabe M; Nakata J; Hemmi C; Masui F; Nakajima T; Suzuki J; Monahan J; Sato H; Masaki T; Ozawa K; Toyo-Oka T
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):901-6. PubMed ID: 11805334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.